FGEN logo

FibroGen (FGEN) Shareholders Equity

Annual Shareholders Equity

-$204.17 M
-$182.72 M-851.96%

December 31, 2023


Summary


Performance

FGEN Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherFGENbalance sheetmetrics:

Quarterly Shareholders Equity

-$243.67 M
-$11.33 M-4.88%

September 30, 2024


Summary


Performance

FGEN Quarterly Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherFGENbalance sheetmetrics:

Shareholders Equity Formula

Shareholders Equity = Total Assets − Total Liabilities

FGEN Shareholders Equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-852.0%0.0%
3 y3 years-148.4%0.0%
5 y5 years-140.1%0.0%

FGEN Shareholders Equity Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-197.6%at low-216.5%at low
5 y5-year-139.6%at low-147.2%at low
alltimeall time-138.6%at low-138.7%at low

FibroGen Shareholders Equity History

DateAnnualQuarterly
Sep 2024
-
-$243.67 M(+4.9%)
Jun 2024
-
-$232.34 M(+1.8%)
Mar 2024
-
-$228.12 M(+11.7%)
Dec 2023
-$204.17 M(+852.0%)
-$204.17 M(+29.9%)
Sep 2023
-
-$157.17 M(+53.7%)
Jun 2023
-
-$102.27 M(+109.4%)
Mar 2023
-
-$48.85 M(+127.8%)
Dec 2022
-$21.45 M(-110.3%)
-$21.45 M(-181.5%)
Sep 2022
-
$26.31 M(-74.7%)
Jun 2022
-
$103.78 M(-34.3%)
Mar 2022
-
$158.05 M(-24.4%)
Dec 2021
$209.15 M(-50.5%)
$209.15 M(-35.8%)
Sep 2021
-
$325.79 M(+25.0%)
Jun 2021
-
$260.58 M(-29.8%)
Mar 2021
-
$371.00 M(-12.1%)
Dec 2020
$422.18 M(-18.2%)
$422.18 M(-6.5%)
Sep 2020
-
$451.66 M(+14.1%)
Jun 2020
-
$395.87 M(-13.6%)
Mar 2020
-
$458.36 M(-11.2%)
Dec 2019
$516.13 M
$516.13 M(-13.2%)
Sep 2019
-
$594.45 M(-5.5%)
Jun 2019
-
$629.03 M(+28.6%)
DateAnnualQuarterly
Mar 2019
-
$489.22 M(-3.9%)
Dec 2018
$509.20 M(-3.6%)
$509.20 M(+8.0%)
Sep 2018
-
$471.31 M(-4.9%)
Jun 2018
-
$495.53 M(-0.8%)
Mar 2018
-
$499.52 M(-5.5%)
Dec 2017
$528.47 M(+239.1%)
$528.47 M(-7.5%)
Sep 2017
-
$571.50 M(+148.4%)
Jun 2017
-
$230.10 M(+74.7%)
Mar 2017
-
$131.70 M(-15.5%)
Dec 2016
$155.84 M(-12.2%)
$155.84 M(-12.6%)
Sep 2016
-
$178.34 M(-7.6%)
Jun 2016
-
$193.11 M(+23.0%)
Mar 2016
-
$156.95 M(-11.6%)
Dec 2015
$177.55 M(-19.8%)
$177.55 M(-18.3%)
Sep 2015
-
$217.28 M(-14.3%)
Jun 2015
-
$253.62 M(+37.4%)
Mar 2015
-
$184.62 M(-16.6%)
Dec 2014
$221.41 M(+177.7%)
$221.41 M(+170.8%)
Sep 2014
-
$81.77 M(-27.0%)
Jun 2014
-
$111.99 M(+40.5%)
Dec 2013
$79.73 M(-15.6%)
$79.73 M
Dec 2012
$94.48 M
-

FAQ

  • What is FibroGen annual stockholders equity?
  • What is the all time high annual shareholders equity for FibroGen?
  • What is FibroGen annual shareholders equity year-on-year change?
  • What is FibroGen quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for FibroGen?
  • What is FibroGen quarterly shareholders equity year-on-year change?

What is FibroGen annual stockholders equity?

The current annual shareholders equity of FGEN is -$204.17 M

What is the all time high annual shareholders equity for FibroGen?

FibroGen all-time high annual stockholders equity is $528.47 M

What is FibroGen annual shareholders equity year-on-year change?

Over the past year, FGEN annual stockholders equity has changed by -$182.72 M (-851.96%)

What is FibroGen quarterly stockholders equity?

The current quarterly shareholders equity of FGEN is -$243.67 M

What is the all time high quarterly shareholders equity for FibroGen?

FibroGen all-time high quarterly stockholders equity is $629.03 M

What is FibroGen quarterly shareholders equity year-on-year change?

Over the past year, FGEN quarterly stockholders equity has changed by $0.00 (0.00%)